These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36535971)

  • 61. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress.
    Ricci F; Bresesti I; LaVerde PAM; Salomone F; Casiraghi C; Mersanne A; Storti M; Catozzi C; Tigli L; Zecchi R; Franceschi P; Murgia X; Simonato M; Cogo P; Carnielli V; Lista G
    Pediatr Res; 2021 Sep; 90(3):576-583. PubMed ID: 33452472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of Surfactant Therapy Using Orogastric Tube for Tracheal Catheterization in Preterm Newborns with Respiratory Distress.
    Tomar RS; Ghuliani R; Yadav D
    Indian J Pediatr; 2017 Apr; 84(4):257-261. PubMed ID: 28050683
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is it feasible to identify preterm infants with respiratory distress syndrome for early extubation to continuous positive airway pressure post-surfactant treatment during retrieval?
    Priyadarshi A; Quek WS; Luig M; Lui K
    J Paediatr Child Health; 2015 Mar; 51(3):321-7. PubMed ID: 25196918
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomised controlled trial in preterm infants comparing prophylactic with selective "less invasive surfactant administration" (pro.LISA).
    Göpel W; Rausch TK; Mitschdörfer B; Mader S; Herting E; König IR; Stichtenoth G;
    Trials; 2023 Sep; 24(1):612. PubMed ID: 37752593
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study.
    Herting E; Kribs A; Härtel C; von der Wense A; Weller U; Hoehn T; Vochem M; Möller J; Wieg C; Roth B; Göpel W;
    Eur J Pediatr; 2020 Aug; 179(8):1309-1313. PubMed ID: 32067100
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Observational Study on Less Invasive Surfactant Administration (LISA) in Preterm Infants<29 Weeks--Short and Long-term Outcomes.
    Teig N; Weitkämper A; Rothermel J; Bigge N; Lilienthal E; Rossler L; Hamelmann E
    Z Geburtshilfe Neonatol; 2015 Dec; 219(6):266-73. PubMed ID: 26550923
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Less invasive surfactant administration and complications of preterm birth.
    Härtel C; Paul P; Hanke K; Humberg A; Kribs A; Mehler K; Vochem M; Wieg C; Roll C; Herting E; Göpel W
    Sci Rep; 2018 May; 8(1):8333. PubMed ID: 29844331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Less invasive surfactant administration (LISA) - ways to deliver surfactant in spontaneously breathing infants.
    Herting E
    Early Hum Dev; 2013 Nov; 89(11):875-80. PubMed ID: 24075206
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants.
    Göpel W; Kribs A; Härtel C; Avenarius S; Teig N; Groneck P; Olbertz D; Roll C; Vochem M; Weller U; von der Wense A; Wieg C; Wintgens J; Preuss M; Ziegler A; Roth B; Herting E;
    Acta Paediatr; 2015 Mar; 104(3):241-6. PubMed ID: 25474712
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway Versus Brief Tracheal Intubation in Neonates Born Preterm.
    Gallup JA; Ndakor SM; Pezzano C; Pinheiro JMB
    J Pediatr; 2023 Mar; 254():17-24.e2. PubMed ID: 36241051
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The minimal invasive surfactant therapy: experience from a low resource setting.
    Ajanwaenyi J; Bamidele O; Osim C; Salami O; Umukoro C; Idaboh T; Chimah U; Okolo A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5177-5183. PubMed ID: 33491516
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome-a randomized controlled trial.
    Auer-Hackenberg L; Brandner J; Hofstätter E; Stroicz P; Hager T; Eichhorn A; Schütz S; Feldner R; Wald M
    BMC Pediatr; 2022 Nov; 22(1):637. PubMed ID: 36333741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Goss KCW; Tauscher MK; Murthy V; Ali SKM; Clark HW; Soll RF; Johnson S; Cheong JLY; Carlin JB; Davis PG;
    JAMA; 2023 Sep; 330(11):1054-1063. PubMed ID: 37695601
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Timing of surfactant treatment in respiratory distress syndrome.
    van Kaam AH; Niemarkt HJ; Onland W
    Semin Fetal Neonatal Med; 2023 Dec; 28(6):101495. PubMed ID: 38012889
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.
    Nakhshab M; Tajbakhsh M; Khani S; Farhadi R
    Pediatr Neonatol; 2015 Apr; 56(2):88-94. PubMed ID: 25264154
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of Outcomes of Less Invasive Surfactant Administration in Prematurely Born Infants in the Delivery Suite and the Neonatal Unit.
    Shetty S; Tolentino D; Kulkarni A; Duffy D; Greenough A
    Am J Perinatol; 2024 May; 41(S 01):e2674-e2678. PubMed ID: 37500076
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
    Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
    JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Criteria for Using INSURE in Management of Premature Babies with Respiratory Distress Syndrome.
    Awaysheh F; Alhmaiedeen N; Al-Ghananim R; Bsharat A; Al-Hasan M
    Med Arch; 2019 Aug; 73(4):240-243. PubMed ID: 31762557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of Initial Respiratory Support Strategies in VLBW Neonates with RDS.
    Afjeh SA; Sabzehei MK; Khoshnood Shariati M; Shamshiri AR; Esmaili F
    Arch Iran Med; 2017 Mar; 20(3):158-164. PubMed ID: 28287810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.